Hou M C, Lin H C, Chen C H, Kuo B I, Perng C L, Lee F Y, Lee S D
Department of Medicine, Veterans General Hospital-Taipei, Taiwan, Republic of China.
Gastrointest Endosc. 1995 Aug;42(2):139-44. doi: 10.1016/s0016-5107(95)70070-6.
To determine the effect of endoscopic variceal sclerotherapy or ligation on portal hypertensive gastropathy, 90 cirrhotic patients with esophageal variceal bleeding were randomized to receive sclerotherapy (n = 44) or ligation (n = 46). Follow-up endoscopic observations of the gastric mucosa were recorded at 3-month intervals after variceal eradication. Clinical characteristics in both groups were similar. Probability for a change in the severity of portal hypertensive gastropathy was not related to method of eradication. Most cases of portal hypertensive gastropathy that changed in severity returned to baseline status with time, but the return was faster after ligation than after sclerotherapy. According to the results of multivariate analyses, sclerosant volume was the only factor associated with a significant difference between the group with static gastropathy (n = 15) and that with dynamic change in gastropathy (n = 23) after sclerotherapy. No relevant factors were found in the patients receiving ligation. We conclude that changes in the severity of portal hypertensive gastropathy after endoscopic variceal sclerotherapy or ligation are reversible. Most cases of gastropathy return to baseline status sooner or later.
为确定内镜下静脉曲张硬化疗法或套扎术对门静脉高压性胃病的影响,将90例肝硬化食管静脉曲张破裂出血患者随机分为硬化疗法组(n = 44)和套扎术组(n = 46)。在静脉曲张根除后,每隔3个月记录一次胃黏膜的随访内镜观察结果。两组的临床特征相似。门静脉高压性胃病严重程度改变的可能性与根除方法无关。大多数严重程度发生改变的门静脉高压性胃病病例随时间推移恢复到基线状态,但套扎术后恢复速度比硬化疗法后更快。根据多变量分析结果,硬化剂用量是硬化疗法后静态胃病组(n = 15)和胃病动态变化组(n = 23)之间存在显著差异的唯一相关因素。接受套扎术的患者未发现相关因素。我们得出结论,内镜下静脉曲张硬化疗法或套扎术后门静脉高压性胃病严重程度的改变是可逆的。大多数胃病病例迟早会恢复到基线状态。